ATRA | Atara Biotherapeutics IncCompany profile
Company profileAtara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. The company was founded in 2012, and since 2014 the company's stock has been publicly traded on Nasdaq under the symbol ATRA. Address611 Gateway Boulevard Products & Services
| NotesResearchInvestor pageinvestors.atarabio.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended BooksBuy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949. The best book on investing ever written. |